StonvexLoading…
StonvexCore line items from AGEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $34.68M | $33.74M | $114.20M | $79.99M | $49.76M |
Operating Income | Not available | $15.05M | $-20.17M | $-34.57M | $-30.02M |
Net Income | Not available | $39.21M | $-3.08M | $7.53M | $-30.01M |
EPS (Diluted) | $-0.33 | $1.02 | $0.00 | $0.37 | $-2.03 |
Total Assets | Not available | $186.46M | $226.80M | $233.89M | $185.22M |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $35.00M | $3.00M | $3.46M | $9.53M |
Free Cash Flow OCF − CapEx | Not available | $-35.95M | $-77.20M | $-60.58M | $-45.85M |
Shares Outstanding | Not available | 38.52M | 35.32M | 32.81M | 30.00M |